Shares of ASP Isotopes Inc. (NASDAQ:ASPI) are rising today after announcing that it had entered into a non-binding memorandum of understanding with a large publicly traded U.S. energy company that operates nuclear power stations.

ASP Enters Nuclear Energy Agreement

Under the terms of the MOU, the U.S. energy company will evaluate options to support QLE’s plans to establish advanced nuclear fuel cycle facilities located in the United States. These facilities are planned to produce high assay low enriched uranium (HALEU) and low enriched uranium plus (LEU+), as well as to provide uranium conversion and deconversion services. The MOU outlines potential terms for providing financial support pursuant to definitive agreements for the supply of enriched uranium.

“This memorandum of understanding represents an important step in QLE’s efforts to help establish a domestic supply chain for advanced nuclear fuels,” said Ryno Pretorius, Chief Executive Officer of Quantum Leap Energy. “We believe interest from a major U.S. energy producer underscores the importance of reliable domestic sources of nuclear fuel. We look forward to advancing technical diligence and evaluating potential pathways toward long-term commercial collaboration.”

Stock Up More Than 30% Over A Year

ASPI is trading 2.8% above its 20-day SMA, but it remains 22.2% below its 100-day SMA, highlighting a short-term bounce inside a still-damaged longer-term trend. Shares are up 37.19% over the past 12 months, but the stock is currently positioned closer to its 52-week low than its 52-week high.

The RSI is at 40.47, which sits in neutral territory but leans toward the weaker side of the range. Meanwhile, MACD is at -0.2978 versus a signal line of -0.3165, a bullish configuration that suggests downside momentum is easing even though the indicator remains below zero.

RSI in the 30–50 range with bullish MACD indicates momentum leaning bullish.

  • Key Resistance: $6.50
  • Key Support: $5.50

Earnings and Analyst Outlook

Looking further out, the next major catalyst for the stock arrives with the March 30, 2026 earnings report.

  • EPS Estimate: Loss of 14 cents (Down from loss of 13 cents YoY)
  • Revenue Estimate: $2.03 million (Up from $1.19 million YoY)
  • Valuation: P/E ratio not meaningful (company is expected to remain unprofitable)

Shares Up In Regular Trading

ASPI Price Action: ASP Isotopes shares were up 6.65% at $5.45 at the time of publication on Friday, according to Benzinga Pro data.

Image: Shutterstock